Fostering regulatory collaboration to improve access to mpox medicines

News Healthcare & Pharma Reports

Date: 25th Oct, 2024 Source: European Medicines Agency (EMA) Country: European Union Original Source

Brief

On 2 October 2024, the European Medicines Agency (EMA) organized a virtual workshop under the International Coalition of Medicines Regulatory Authorities (ICMRA), discussing considerations on mpox vaccine development and availability. International regulators stressed the need for large clinical trials to generate evidence required for rapid approval of mpox medicines.

This content is restricted.

Highlights content goes here...

This content is restricted.

European Medicines Agency (EMA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Fostering regulatory collaboration to improve access to mpox medicines

Brief

European Medicines Agency (EMA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Fostering regulatory collaboration to improve access to mpox medicines

Brief

European Medicines Agency (EMA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.